Detalhe da pesquisa
1.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 266-274, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396818
2.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
3.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330065
4.
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations.
Int J Mol Sci
; 21(22)2020 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33182542
5.
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
J Cell Physiol
; 233(3): 2313-2323, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710865
6.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 398, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460777
7.
The obesity paradox in cancer: clinical insights and perspectives.
Eat Weight Disord
; 23(2): 185-193, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492860
8.
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
Br J Cancer
; 114(1): 30-6, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26575603
9.
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting.
Oncologist
; 21(3): 283-91, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865589
10.
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories.
J Pers Med
; 13(10)2023 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37888038
11.
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer.
Nutrition
; 105: 111858, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323147
12.
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
J Immunother Cancer
; 11(11)2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016718
13.
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
Ther Adv Med Oncol
; 15: 17588359221138657, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936199
14.
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting.
Cancers (Basel)
; 15(9)2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173916
15.
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy.
J Pers Med
; 13(8)2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623530
16.
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 73, 2023 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684252
17.
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents.
Cancers (Basel)
; 14(17)2022 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077601
18.
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives.
Cancers (Basel)
; 14(9)2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565291
19.
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Cancer Treat Rev
; 110: 102454, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987149
20.
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.
Front Oncol
; 12: 1053035, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36741700